Wednesday, November 1, 2017
Guest Post from Sandro Santagata, MD, PhD: Papillary Craniopharyngioma Trial
I am pleased to present a guest post from Dr. Sandro Santagata of Brigham and Women’s Hospital/Dana Farber Cancer Center, who writes:
Our group of collaborators has recently opened a Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas that is sponsored by the Alliance for Clinical Trials in Oncology.
The eligibility criteria are listed here: https://clinicaltrials.gov/ct2/show/NCT03224767
The trial is based on work published in these two papers:
I am happy to answer any questions that our colleagues may have about this trial. email@example.com
This just in from today's guest blogger Dr. Rachael Vaubel: Brain Pathology “Under your Microscope” is finally up and running! For ...
Remarkable en bloc dissection of human central and peripheral nervous system accomplished at University of ColoradoShannon Curran, MS with her dissection Shannon Curran, a graduate student in the Modern Human Anatomy Program at the University of Co...
The meticulously extracted nervous system of a 19th-century woman on display at Hahnemann Medical CollegeLast summer I put up a post about a remarkable whole nervous system dissection that was carried out at the University of Colorado School of ...